Basic Information
Next&Bio Inc. is committed to providing "customized" treatments for patients and "low-cost, high-efficiency" drug development solutions for pharmaceutical developers through its next-generation precision healthcare platform, making Unmnet needs a new type of patient for treating advanced cancer and degenerative brain diseases.
Next&Bio Inc.
Seoul,SeoulSpecialCity,SouthKorea
15~50 people
November 29, 2018
nextandbio@nextandbio.com

